Proxy Materials

Avalo Therapeutics, Inc. Filed 2024-03-28 Acc 0001628280-24-013442

Documents 1

2024-06-27 DEFA14A Proxy Materials
2024-04-03 3 Initial Statement of Ownership
2024-03-29 10-K Annual Report
2024-03-29 8-K Results of operations
2024-03-28 DEFA14A Proxy Materials
2024-03-28 8-K Material agreement · Acquisition or sale completed · Delisting notice · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
2023-12-07 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading a8-ktransactionpipe_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…